Company information:
Covid Biopharma Limited (No: 12570359)
Address: 1ST FLOOR 40-44, NEWMAN STREET, LONDON, W1T 1QD, ENGLAND
Status: Active
Incorporated: 23-Apr-2020
Accounts Next Due: 30-Sep-2024
Next Confirmation Statement Due: 05-Jun-2024
Industry Class: 72110 - Research and experimental development on biotechnology
Current Director: CHRISTOPHER GALLEN ( DOB: Dec-1950 From: Apr-2020 )
Current Director: DANIEL ARTHUR HALLGARTEN ( DOB: Nov-1961 From: Apr-2020 )
Current Director: DANIEL ARTHUR HALLGARTEN ( DOB: Nov-1961 From: Apr-2020 )
Current Director: GABOR ISTVAN ILLES ( DOB: Jun-1976 From: Apr-2020 )
Current Director: PETER KADAS ( DOB: Feb-1962 From: Apr-2020 )
Current Director: ENIKO TOKE ( DOB: Apr-1980 From: Apr-2020 )
Persons of Significant Control:
Mr Peter Kadas, 1st Floor 40-44, Newman Street, London, W1T 1QD, England: Ownership of shares – More than 25% but not more than 50%, Ownership of voting rights - More than 25% but not more than 50% (Notified: 2020-04-23)
Company Accounts Summary (£)
| Item | 2020-12 | 2021-12 | 2022-12 | 2023-12 | Chart |
|---|---|---|---|---|---|
| Called up share capital not paid, not expressed as current asset | 100 | 100 | 100 | 100 | 100.0,100.0,100.0,100.0 |
| Current assets / Cash at bank and on hand | 0.0,0.0,0.0,0.0 | ||||
| Net assets (liabilities) | 100 | 100 | 100 | 100 | 100.0,100.0,100.0,100.0 |
| Equity / share capital and reserves | 100 | 100 | 100 | 100 | 100.0,100.0,100.0,100.0 |